Fabino Enterprises (BOM:543444) Notes Receivable: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543444 Fabino Enterprises Ltd BOM:543444
68 GF Score
Price ₹20.31
GF Value ₹37.57
! 5 Warning Signs
View Full Analysis

What is Fabino Enterprises Notes Receivable?

Fabino Enterprises BOM:543444 68 Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:543444 with a GF Score™ of 68/100 and a GF Value™ of ₹37.57. The stock has 5 warning signs investors should review.

Fabino Enterprises's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Fabino Enterprises Notes Receivable Related Terms

Fabino Enterprises Notes Receivable Historical Data

* Premium members only.

The historical data trend for Fabino Enterprises's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fabino Enterprises Notes Receivable Chart

Fabino Enterprises Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Fabino Enterprises Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543444
68GF Score
Fabino Enterprises Ltd BOM:543444
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fabino Enterprises Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Fabino Enterprises (BOM:543444) has a Notes Receivable of ₹0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Fabino Enterprises and its competitors.
Is Fabino Enterprises' Notes Receivable too high?
Fabino Enterprises' current Notes Receivable is ₹0.0 Mil. Overall, Fabino Enterprises has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Fabino Enterprises' Notes Receivable compare to ZTS and UTHR?
Fabino Enterprises' Notes Receivable of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Fabino Enterprises and its competitors. Fabino Enterprises's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabino Enterprises stock overvalued right now?
Fabino Enterprises (BOM:543444) has a current Notes Receivable of ₹0.0 Mil. The stock's GF Value™ is ₹37.57, compared to a current price of ₹20.31 — trading 45.9% below its estimated fair value. The current Notes Receivable is ₹0.0 Mil. Fabino Enterprises' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Fabino Enterprises (BOM:543444), the current Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fabino Enterprises (BOM:543444) Overvalued in 2026?

Based on GuruFocus' analysis, Fabino Enterprises stock appears to be undervalued. The current stock price of ₹20.31 is trading 45.9% below its estimated GF Value™ of ₹37.57.

Key valuation signals for BOM:543444:

  • Notes Receivable: ₹0.0 Mil
  • GF Value™: ₹37.57 vs. price of ₹20.31 (45.9% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the BOM:543444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fabino Enterprises Business Description

Address Murthal Road, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
68GF Score

Get the complete analysis for BOM:543444

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹20.31
Price
₹37.57
GF Value